Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.

Historical epidemiological analysis has demonstrated an association between urbanisation and growing cancer burden across the ...

Palvella Therapeutics is set to expand Phase III SELVA trial to include subjects aged three to five years old.

Q32 Bio has stopped a Phase II trial of its former lead renal disease candidate as it focuses on its alopecia areata ...

BMS has reported that the Phase II TRANSCEND FL trial assessing Breyanzi, met its primary endpoint in the marginal zone ...